Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9602330rdf:typepubmed:Citationlld:pubmed
pubmed-article:9602330lifeskim:mentionsumls-concept:C1704242lld:lifeskim
pubmed-article:9602330lifeskim:mentionsumls-concept:C0069515lld:lifeskim
pubmed-article:9602330lifeskim:mentionsumls-concept:C1514559lld:lifeskim
pubmed-article:9602330lifeskim:mentionsumls-concept:C0596263lld:lifeskim
pubmed-article:9602330lifeskim:mentionsumls-concept:C1704824lld:lifeskim
pubmed-article:9602330lifeskim:mentionsumls-concept:C0332125lld:lifeskim
pubmed-article:9602330pubmed:issue4lld:pubmed
pubmed-article:9602330pubmed:dateCreated1998-7-16lld:pubmed
pubmed-article:9602330pubmed:abstractTextConflicting data on c-erbB-2 overexpression in gastric carcinomas can be found in the literature with regard to overall prevalence, prognostic significance and the histological type according to Lauren. The majority of these studies have focused on advanced gastric carcinomas whereas data on c-erbB-2 overexpression in early gastric carcinomas, especially of Caucasian origin, are relatively sparse. We therefore examined a series of Caucasian early gastric carcinomas to assess overall c-erbB-2 overexpression and to correlate c-erbB-2 overexpression, if any, with the type of growth pattern and the Lauren type.lld:pubmed
pubmed-article:9602330pubmed:languageenglld:pubmed
pubmed-article:9602330pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9602330pubmed:citationSubsetIMlld:pubmed
pubmed-article:9602330pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9602330pubmed:statusMEDLINElld:pubmed
pubmed-article:9602330pubmed:monthAprlld:pubmed
pubmed-article:9602330pubmed:issn0309-0167lld:pubmed
pubmed-article:9602330pubmed:authorpubmed-author:TytgatG NGNlld:pubmed
pubmed-article:9602330pubmed:authorpubmed-author:BlokPPlld:pubmed
pubmed-article:9602330pubmed:authorpubmed-author:DekkerWWlld:pubmed
pubmed-article:9602330pubmed:authorpubmed-author:CraanenM EMElld:pubmed
pubmed-article:9602330pubmed:authorpubmed-author:OfferhausG...lld:pubmed
pubmed-article:9602330pubmed:issnTypePrintlld:pubmed
pubmed-article:9602330pubmed:volume32lld:pubmed
pubmed-article:9602330pubmed:ownerNLMlld:pubmed
pubmed-article:9602330pubmed:authorsCompleteYlld:pubmed
pubmed-article:9602330pubmed:pagination335-9lld:pubmed
pubmed-article:9602330pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:9602330pubmed:meshHeadingpubmed-meshheading:9602330-...lld:pubmed
pubmed-article:9602330pubmed:meshHeadingpubmed-meshheading:9602330-...lld:pubmed
pubmed-article:9602330pubmed:meshHeadingpubmed-meshheading:9602330-...lld:pubmed
pubmed-article:9602330pubmed:meshHeadingpubmed-meshheading:9602330-...lld:pubmed
pubmed-article:9602330pubmed:meshHeadingpubmed-meshheading:9602330-...lld:pubmed
pubmed-article:9602330pubmed:meshHeadingpubmed-meshheading:9602330-...lld:pubmed
pubmed-article:9602330pubmed:meshHeadingpubmed-meshheading:9602330-...lld:pubmed
pubmed-article:9602330pubmed:meshHeadingpubmed-meshheading:9602330-...lld:pubmed
pubmed-article:9602330pubmed:year1998lld:pubmed
pubmed-article:9602330pubmed:articleTitleNo evidence for c-erbB-2 overexpression in gastric carcinogenesis.lld:pubmed
pubmed-article:9602330pubmed:affiliationDepartment of Gastroenterology, University Hospital Vrije Universiteit, Amsterdam, The Netherlands.lld:pubmed
pubmed-article:9602330pubmed:publicationTypeJournal Articlelld:pubmed